Cardiotropic Viruses in Cardiac Surgery Patients Without Clinical Evidence of Myocarditis or Myocarditic Sequelae

NCT ID: NCT00511160

Last Updated: 2016-10-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-08-31

Study Completion Date

2010-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Myocarditis is mainly caused by cardiotropic viruses. In recent time viruses found in endomyocardial biopsies mainly consist of parvovirus B19 (PVB19) and human herpesvirus 6 (HHV6). A definite causal link between virus-genome detection of PVB19 and/or HHV6 (via pcr techniques)and cardiac inflammation and dysfunction is however still missing.

Primary objective:

To determine the prevalence of PVB19 and HHV6 virus genome in heart muscle biopsies of cardiac surgery patients without clinical evidence of myocarditis or myocarditic sequelae

Secondary objectives:

1. Correlation of non-invasive myocarditis screening exams (cardiac magnetic resonance, ecg, history, inflammatory markers) with biopsy results
2. Prognostic value of virus prevalence for the postoperative course

Primary hypothesis:

Patients without clinical evidence of myocarditis or myocarditic sequelae demonstrate to a significant lesser extent inflammatory activity and virus genome in their myocardium as compared to patients being clinical suspicious for myocarditis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prospective monocentric study with to 2 arms

Study arm: Cardiac surgery group, Control arm: Routine cardiology group Minimum of 100 patients included into the study arm

Inclusion criteria for the study arm:

Adult patients having cardiac surgery done under use of cardiopulmonary bypass

Data collection:

Past medical history, ecg, prior cardiovascular imaging (echo, ventriculography), cardiac magnetic resonance imaging (CMR), serologic studies, work-up of endomyocardial biopsies (histology, molecular-pathology, follow-up CMR.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myocarditis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

S

Study arm: Cardiac surgery group

Group Type ACTIVE_COMPARATOR

Myocardial biopsies with TRU CUT 14 Gauge needle

Intervention Type PROCEDURE

Myocardial needle biopsy and right atrial appendectomy

C

Routine cardiology group

Group Type ACTIVE_COMPARATOR

Endomyocardial biopsies

Intervention Type PROCEDURE

The control arm C consists of routine-workup of patients with suspected myocarditis, independent of the study arm C, but with analogous screening methods and comparable biopsy sampling

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Myocardial biopsies with TRU CUT 14 Gauge needle

Myocardial needle biopsy and right atrial appendectomy

Intervention Type PROCEDURE

Endomyocardial biopsies

The control arm C consists of routine-workup of patients with suspected myocarditis, independent of the study arm C, but with analogous screening methods and comparable biopsy sampling

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

TRU CUT 14 Gauge needle

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cardiac surgery with cardiopulmonary bypass

Exclusion Criteria

* No ability to give informed consent
* presence of so far accepted parvovirus/herpesvirus associated comorbidities
* contraindications for magnetic resonance
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Udo Sechtem

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Udo Sechtem

Prof. Udo Sechtem

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Udo P Sechtem, MD

Role: STUDY_CHAIR

Head of Cardiology, Robert Bosch Krankenhaus, Stuttgart, Germany

Ulrich FW Franke, MD

Role: STUDY_DIRECTOR

Head of Cardiovascular Surgery, Robert Bosch Krankenhaus, Stuttgart, Germany

Reinhardt Kandolf, MD

Role: STUDY_DIRECTOR

Director of Institute of Molecular Pathology University Tuebingen, Germany

Hannibal Baccouche, MD

Role: PRINCIPAL_INVESTIGATOR

Department of Cardiology, Robert Bosch Krankenhaus, Stuttgart, Germany

Hardy Baumbach, MD

Role: PRINCIPAL_INVESTIGATOR

Department of Cardiovascular Surgery, Robert Bosch Krankenhaus Stuttgart, Germany

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Robert Bosch Krankenhaus, Auerbachstrasse 110

Stuttgart, Baden-Wurttemberg, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RBK103

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Incisions for Cardiac Surgery
NCT00229892 TERMINATED
Cryoanalgesia Study
NCT05859061 COMPLETED NA